Insights on Baricitinib for Atopic Dermatitis

In this podcast, Dr Jonathan Silverberg discusses baricitinib in relation to his study, “Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16”.

Jonathan Silverberg, MD, PhD, MPH, is an associate professor of dermatology and director of the patch testing clinic at the George Washington University School of Medicine and Health Sciences in Washington, DC. He is also the director of Clinical Research and Contact Dermatitis. His area of expertise is in inflammatory skin disease, focused on atopic dermatitis (AD) and contact dermatitis. He has a background in advanced management of AD, hand eczema, chronic itch, psoriasis, hidradenitis suppurativa, and other chronic inflammatory skin disorders. His subspecialty revolves around allergy patch testing, phototesting, and photopatch testing.

Transcript:
​​​​​​​Coming soon